| HOLD | 2.180 | Peter Hodson | (Market call minute.)Likes the potential but in this environment the stock has been killed. | 2008-07-08 | |
| STRONG BUY | 3.400 | Alex Ruus | Extremely excited about the opportunity for the company. Has multi-billion-dollar potential. One product is for HDL, good cholesterol. Also have a food additive business. Not widely covered. | 2008-04-22 | |
| STRONG BUY | 3.900 | Hugh Cleland, CFA | Krill oil that has a number of therapeutic benefits. Just signed an agreement for global distribution of an omega 3 product. Just got a patent on their pharmaceutical product for boosting of HDL levels. | 2008-04-02 | |
| PAST TOP PICK | 3.480 | Hugh Cleland, CFA | (Top pick, March 26 2007. Down 45%) The companies fundamentals have done nothing but improve over last 12 months. | 2008-03-31 | |
| TOP PICK | 3.480 | Hugh Cleland, CFA | The fundamentals have improved dramatically as the stock has fallen. The product will be likely implemented within 5 years. | 2008-03-31 | |
| TOP PICK | 3.330 | Hugh Cleland, CFA | Has had a bad 12 months even as the fundamentals have built strongly in the right direction. He looks at the stock as having the biggest upside in his portfolio in the next 2 to 3 years. | 2008-03-04 | |
| BUY | 3.350 | Alex Ruus | Fairly volatile. Basing quite nicely in the low $3's. Most exciting part is the pharmaceutical potential with their krill oil, which increases good cholesterol. | 2008-02-25 | |
| STRONG BUY | 3.710 | Alex Ruus | Cholesterol treatment. Great opportunity to be buying right now. Good developments over the last 3 or 4 months and more to come over the next 2 years. Long-term holding. | 2008-02-04 | |
| TOP PICK | 4.200 | Hugh Cleland, CFA | (A Top Past Pick Dec14/06. Down 14.4%.) Company fundamentals are still good. Adding the 3 parts of the business you can get anywhere from $12 to $40 plus. GSK acquisition of Reliant is a huge validation that big Pharma would be willing to pay big $’s for a pharmaceuticalized version of NKO. | 2007-12-27 | |
| TOP PICK | 4.050 | Hugh Cleland, CFA | Patented product from krill oil boosts HDL significantly as well as helping LDL. Pulled back with the market as well as impatience on the pharma side. Dr. Nissen of the Cleveland clinics has joined on with their advisory board. | 2007-11-23 | |
| BUY | 4.120 | Alex Ruus | Sell krill oil for increasing HDL. Can’t understand the recent poor market performance as last month they announced a new Scientific Advisory board headed by Steven Nissen, chairman of the Cleveland Dept. of Cardiovascular Medicine plus 4 other renowned scientists. | 2007-11-05 | |
| TOP PICK | 5.050 | Hugh Cleland, CFA | (A Past Top Jan 245/07. Up 11.3 %.) Krill oil. Extraordinarily volatile. Pronova, which distributes prescription fish oil products, is going public in Europe with this. A fantastic validation of what this company is doing. Still a Buy. | 2007-09-28 | |
| TOP PICK | 4.610 | Hugh Cleland, CFA | (A Top Pick Sept 7/06. Up 64.5%.) Has never been in a stronger fundamental position. Recent contract is a really big endorsement of both their patents and what they can do in food ingredients. Recent research deal with Nestlé's. | 2007-09-07 | |
| BUY | 3.750 | Alex Ruus | A little bit of a controversial name. Has 3 different businesses. 1) Krill oil sold through health food stores for cholesterol. 2) Early-stage agreements with 2 large companies on Nutriceutical. | 2007-09-04 | |
| DON'T BUY | 4.350 | Jean-Francois Tardif | Uses fish oil to increase good cholesterol and lower bad. Company is doing really well, but the stock went up too fast. Also the market is not willing to buy new ideas/emerging companies. | 2007-08-07 | |
| TOP PICK | 7.600 | Hugh Cleland, CFA | (A Top Pick Sept 7/06. Up 177%.) Product increases HDL cholesterol | 2007-05-24 | |
| BUY | 7.940 | Jeff Parent | A lot of volume and a lot of movement. Very steady rise. Every time it has come down to the 50-day moving average it has bounced off. Every time the price moves $1 over the 50-day moving average, you might want to take some profit if you have a position that is 20% of your net liquid assets. | 2007-05-23 | |
| BUY | 8.150 | Alex Ruus | A great performing stock but has a lot further to go. Fantastic company that is under appreciated by the market. Have 3 legs. Most exciting is the pharmaceutical, which uses krill to make a cholesterol product to raise HDL levels. Also makes an alternative to omega-3. | 2007-05-07 | |
| DON'T BUY | 7.430 | Peter Brieger | Too much of a risk for him. It depends on Krill which he feels may be a risky, supply. | 2007-05-02 | |
| Comment | 7.750 | Peter Brieger | They harvest a certain type of krill, which is very good for cholesterol. Looking into the stock. An interesting concept. | 2007-04-18 | |
| TOP PICK | 6.350 | Hugh Cleland, CFA | (A Top Pick Sept 7/06. Up 97.3%.) In the cholesterol space. Very early stage HDL treatment. | 2007-03-26 | |
| BUY | 6.350 | Hugh Cleland, CFA | Cholesterol management. Study by McGill had HDL up by 51% and LDL down by over 30%. Generating cash on a consistent basis. Expects good upside. | 2007-03-26 | |
| TOP PICK | 4.480 | Hugh Cleland, CFA | (A Top Pick Sept 7/06. Up 41.9%.) This will be the year of catalysts in the 3 areas of their business. HDL therapy is getting good results. | 2007-01-24 | |
| TOP PICK | 4.850 | Hugh Cleland, CFA | (A Top Pick Sept 7/06. Up 67.6%.) Product carries Omega 3s better than the competition. Sustainable competitive advantage. Results show an increase in HDL. | 2006-12-14 | |
| STRONG BUY | 3.290 | Alex Ruus | Very bullish on this company. There are 3 different businesses and each one is worth more than the market cap of the company. | 2006-11-22 | |
| TOP PICK | 2.960 | Hugh Cleland, CFA | A likely player in the staten market. Their product increases HDL cholesterol dramatically. They also have other opportunities such as omega situations. | 2006-09-07 | |
| TOP PICK | 2.500 | Howard Sutton | Higher risk, but an extremely high return opportunity. They exploit marine biomass. They use krill oil for health products. | 2006-05-24 | |
Experts that have talked about Neptune Tech & Bioresource
Rss Top Picks Feed
